Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity

Mintz‐Hittner H.; Kennedy K.; Chuang A.

doi:10.1056/nejmoa1007374

← Today's brief

Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity

Mintz‐Hittner H. et al. · The New England journal of medicine · Saturday, January 1, 2011

Funding Not reported

Source

Mintz‐Hittner H. et al.. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. The New England journal of medicine. Saturday, January 1, 2011.
doi:10.1056/nejmoa1007374Read original ↗

Generated, then checked against the source · how this brief was built →

Sign in to rate and bookmark articles

Automated evidence summary, checked against the source. Not medical advice. Verify with the original publication.